4543 On Other Exchanges
Symbol
Exchange
4543 is not on other exchanges.

terumo corp (4543) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TERUMO CORP (4543)
\

Related News

No related news articles were found.

terumo corp (4543) Related Businessweek News

No Related Businessweek News Found

terumo corp (4543) Details

Terumo Corporation manufactures and sells medical devices and services worldwide. It provides products for use in cardiothoracic surgery, interventional procedure, and medicine transfusion. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems. It also provides interventional oncology devices, such as micro catheters and guide wires, micro balloon catheters, and drug-elutable beads; cardiopulmonary bypass systems comprising oxygenators with integrated arterial filters, heart-lung machines, and devices for operating a centrifugal pumps for extracorporeal life support systems; and thoracic vascular and abdominal vascular grafts. In addition, the company offers infusion systems; closed anticancer drug infusion systems; blood glucose monitoring systems, digital blood pressure monitors, digital thermometers, pulse oximeters, walking intensity monitors, body composition monitors, and HR joint meter/monitors; analgesics; sprayable adhesion barrier gels; pharmaceuticals and nutritional supplements; and peritoneal dialysis devices and fluids. Further, it provides other consumer healthcare products, such as basal thermometers, fall prevention products, oral care products, and urine test strips; and blood bag systems with leukocyte reduction filters, automated blood collection and blood component processing systems, pathogen reduction technology systems, centrifugal apheresis systems, cell expansion systems, and autologous cell processing devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.

22,441 Employees
Last Reported Date: 06/28/17
Founded in 1921

terumo corp (4543) Top Compensated Officers

Senior Executive Officer & Director
Total Annual Compensation: ¥141.0M
Compensation as of Fiscal Year 2017.
terumo corp
Terumo Corporation Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Earnings and Dividend Guidance for the Year Ending March 31, 2018

Terumo Corporation reported consolidated earnings results for the nine months ended December 31, 2017. For the period, the company's net sales were JPY 436,955 million against JPY 374,394 million a year ago. Operating income JPY 72,374 million against JPY 58,904 million a year ago. Ordinary income was JPY 70,663 million against JPY 52,204 million a year ago. Profit attributable to owners of parent was JPY 63,485 million or JPY 167.86 per diluted share against JPY 31,822 million or JPY 81.79 per diluted share a year ago. Income before income taxes was JPY 71,330 million against JPY 44,621 million a year ago. For the year ending March 31, 2018, the company expects consolidated net sales of JPY 588,000 million, operating income of JPY 92,000 million, ordinary income of JPY 89,500 million and profit attributable to owners of parent of JPY 76,000 million or JPY 215.70 per share. The company provided dividend guidance for the full year ending March 31, 2018. For the year, the company expects to pay dividend of JPY 23.00 per share against JPY 22.00 per share paid a year ago.

Terumo Corporation Announces Management Changes

Terumo Corporation announced that it has resolved a change of its Directors and Executive Officers. Toshiaki Takagi has been appointed from current title Director and Managing Executive Officer, Chief Quality Officer (CQO) Quality Assurance Dept, Post-Market Surveillance an Vigilance Dept, Environmental Management Dept, Production Dept and Procurement Dept to new title Director and Senior managing Executive Officer, Chief Quality Officer (CQO) Quality Assurance Dept, Post-Market Surveillance an Vigilance Dept, Environmental Management Dept, Production Dept, Procurement Dept, Intellectual Property Dept and Terumo Medical Pranex, as of April 1, 2018. Hideo Arase has been appointed from current title Director and Senior Executive Officer, Regional Representative, India and Asia Pacific Managing Director, Terumo Asia Holdings Pte. Ltd. to new title Director and Corporate Advisor, as of April 1, 2018. Kazuaki Kitabatake has been appointed from current title Managing Executive Officer Investor Relations, Corporate Communication Dept, International Business Dept, General Affairs Dept, Design Planning Dept, Global Talent Management CSR to new title Managing Executive Officer Investor Relations, CSR, Corporate Communication Dept, Design Planning Dept, General Affairs Dept, International Business Dept India and Asia Pacific Region, as of April 1, 2018. Hikaru Samejima has been appointed from current title Senior Executive Officer President, Cardiac and Vascular Company, Division President, Interventiona Systems Division, Cardiac and Vascular Company to new title Managing Executive Officer President, Cardiac and Vascular Company, Division President, Interventional Systems Division, Cardiac and Vascular Company, as of April 1, 2018. Kyo Nishikawa has been appointed from current title Executive Officer Regional Representative, Eastern Europe, Russia, Middle East and Africa, Managing Director and BOD Chairman, Terumo Europe N.V. to new title Senior Executive Officer, Chief Human Resources Officer (CHRO), Human Resources Dept, Human Resources Development Dept, Regional Representative, Eastern Europe, Russia, Middle East and Africa, Managing Director and BOD Chairman, Terumo Europe N.V. as of April 1, 2018. Juichi Takeuchi has been appointed from current title Executive Officer President and CEO, Terumo Americas Holding Inc. Regional Representative, Latin America General Hospital Company (North America) to new title Senior Executive Officer, President and CEO, Terumo Americas Holding, Inc, Regional Representative, Latin America General Hospital Company (North America) as of April 1, 2018. Toshihiko Osada has been appointed from current title Executive Officer, General Manager, Strategic Planning Dept to new title Senior Executive Officer, General Manager, Strategic Planning Dept. as of April 1, 2018. Probir Das has been appointed from current title Executive Officer, Managing Director, Terumo India Private Limited to new title Executive Officer, Regional Representative, India and Asia Pacific, Managing Director, Terumo Asia Holdings Pte. Ltd. Managing Director, Terumo India Private Limited as of April 1, 2018. Tomoko Manabe has been appointed from current title General Manager, Terumo Medical Pranex, Deputy General Manager, Human Resources Development Dept. to new title Executive Officer, General Manager, Terumo Medical Pranex (Human Resources Development Dept.) as of April 1, 2018. Norimasa Kunimoto has been appointed from current title General Manager, Secretarial Office to new title Executive Officer General Manager, Secretarial Office, as of April 1, 201. Kyo Nishikawa has been appointed from current title Senior Executive Officer Chief Human Resources Officer (CHRO) Human Resources Dept, Human Resources Development Dept, Regional Representative, Eastern Europe, Russia, Middle East and Africa Managing Director and BOD Chairman, Terumo Europe N.V. to new title Senior Executive Officer Chief Human Resources Officer (CHRO), Human Resources Dept, Human Resources Development Dept, as of July 1, 2018. Norimasa Kunimoto has been appointed From current title Executive Officer, General Manager, Secretarial Office to new title Executive Officer Regional Representative, Eastern Europe, Russia, Middle East and Africa, Managing Director and BOD Chairman, Terumo Europe N.V. as of July 1, 2018.

Terumo Corporation, Q3 2018 Earnings Call, Feb 08, 2018

Terumo Corporation, Q3 2018 Earnings Call, Feb 08, 2018

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4543 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4543.
View Industry Companies
 

Industry Analysis

4543

Industry Average

Valuation 4543 Industry Range
Price/Earnings 27.1x
Price/Sales 3.8x
Price/Book 3.9x
Price/Cash Flow 26.6x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TERUMO CORP, please visit www.terumo.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.